LENZ Therapeutics, Inc.(LENZ:US)
Market Cap$102.53M
Key Metrics
Price$3.27
Revenue (TTM)$20.99M
Holders Revenue (TTM)-
Gross Profit (TTM)$825K
Earnings (TTM)-$109M
EBITDA (TTM)-$117.98M
Op. Margin (TTM)-563.83%
Dividend Yield-
Holders Yield-
Cash on hand$24.77M
Total Assets$272.54M
Net Assets$246.49M
Total Debt$673K
Key Metrics
Price$3.27
Revenue (TTM)$20.99M
Holders Revenue (TTM)-
Gross Profit (TTM)$825K
Earnings (TTM)-$109M
EBITDA (TTM)-$117.98M
Op. Margin (TTM)-563.83%
Dividend Yield-
Holders Yield-
Cash on hand$24.77M
Total Assets$272.54M
Net Assets$246.49M
Total Debt$673K
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.9M | $1.59M | $12.5M | $5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | $1.08M | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | $825K | - | - | - | - | - | - | - | - | - | - | - | - |
| $44.96M | $39.63M | $31.39M | $21.86M | $16.93M | $15.23M | $12.95M | $14.35M | $16.09M | $19.87M | $14.96M | $12.62M | $9.13M | |
| Research and Development | $0 | $0 | $3.79M | $9.06M | $5.82M | $5.87M | $6.45M | $6.95M | $10.54M | $17M | $12.64M | $10.33M | $7.63M |
| Selling, General, and Administrative | $44.96M | $39.63M | $27.6M | $12.8M | $11.11M | $9.36M | $6.49M | $7.41M | $5.55M | $2.86M | $2.32M | $2.29M | $1.5M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$44.14M | -$38.46M | -$18.89M | -$16.86M | -$16.93M | -$15.23M | -$12.95M | -$14.35M | -$16.09M | -$19.87M | -$14.96M | -$12.62M | -$9.13M |
| $2.65M | $2.57M | $2.19M | $2.45M | $2.31M | $2.57M | $2.73M | $4.1M | -$560K | $985K | $233K | -$54K | $1K | |
| Non-Operating Interest Income | $2.64M | $2.99M | $2.2M | $2.25M | $2.32M | $2.57M | $2.74M | $2.46M | $788K | $1.09M | $251K | $0 | - |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | $3K | -$417K | -$14K | $199K | -$11K | $8K | -$6K | $1.64M | -$1.35M | -$101K | -$18K | -$54K | $1K |
Income Before Tax | -$41.49M | -$35.89M | -$16.7M | -$14.41M | -$14.62M | -$12.65M | -$10.22M | -$10.25M | -$16.65M | -$18.88M | -$14.73M | -$12.67M | -$9.13M |
Income Tax | - | $2K | $0 | $500K | - | - | - | - | - | - | - | - | $303K |
Net Income | -$41.49M | -$35.9M | -$16.7M | -$14.91M | -$14.62M | -$12.65M | -$10.22M | -$10.25M | -$16.65M | -$18.88M | -$14.73M | -$12.67M | -$9.43M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$41.49M | -$35.9M | -$16.7M | -$14.91M | -$14.62M | -$12.65M | -$10.22M | -$10.25M | -$16.65M | -$18.88M | -$14.73M | -$12.67M | -$9.43M |
Shares Outstanding (Basic) | 31.35M | 31.07M | 28.54M | 28.08M | 27.53M | 27.49M | 27.17M | 25.61M | 4.72M | 25.53M | 25.53M | 25.53M | - |
Shares Outstanding (Diluted) | 31.35M | 31.07M | 28.54M | 28.08M | 27.53M | 27.49M | 27.17M | 25.61M | 4.72M | 25.53M | 25.53M | 25.53M | - |
EPS (Basic) | -$1.32 | -$1.16 | -$0.59 | -$0.53 | -$0.53 | -$0.46 | -$0.38 | -$0.40 | -$3.53 | -$0.74 | -$0.58 | -$0.50 | - |
EPS (Diluted) | -$1.32 | -$1.16 | -$0.59 | -$0.53 | -$0.53 | -$0.46 | -$0.38 | -$0.40 | -$3.53 | -$0.74 | -$0.58 | -$0.50 | - |
EBIT | -$44.14M | -$38.46M | -$18.89M | -$16.86M | -$16.93M | -$15.23M | -$12.95M | -$14.35M | -$16.09M | -$19.87M | -$14.96M | -$12.62M | -$9.13M |
EBITDA | -$44.02M | -$38.36M | -$18.76M | -$16.84M | -$16.9M | -$15.2M | -$12.94M | -$14.33M | -$16.08M | -$19.86M | -$14.96M | -$12.61M | -$9.12M |